Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) Assets Average (2016 - 2025)

Altimmune (ALT) has disclosed Assets Average for 15 consecutive years, with $204.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Assets Average rose 27.27% to $204.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $204.4 million, a 27.27% increase, with the full-year FY2024 number at $175.0 million, down 16.19% from a year prior.
  • Assets Average was $204.4 million for Q3 2025 at Altimmune, up from $173.8 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $260.8 million in Q2 2021 to a low of $143.6 million in Q4 2024.
  • A 5-year average of $200.0 million and a median of $199.5 million in 2024 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: surged 370.37% in 2021, then fell 25.67% in 2025.
  • Altimmune's Assets Average stood at $227.9 million in 2021, then fell by 5.17% to $216.1 million in 2022, then dropped by 12.72% to $188.6 million in 2023, then decreased by 23.87% to $143.6 million in 2024, then surged by 42.35% to $204.4 million in 2025.
  • Per Business Quant, the three most recent readings for ALT's Assets Average are $204.4 million (Q3 2025), $173.8 million (Q2 2025), and $148.3 million (Q1 2025).